Mar 25, 2020
Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs
Mar 09, 2020
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Mar 05, 2020
Worldwide Cancer Generics Industry Insights, 2018-2026: Comprehensive Insights on 43 Drugs & 29 Players
Feb 27, 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Feb 24, 2020
Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
Feb 18, 2020
Mylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020
Feb 13, 2020
Global Anti-Thyroid Drugs Market Research Report 2020 - Mylan, Abbott Labs, GlaxoSmithKline, Merck, and AbbVie are Dominating
Jan 27, 2020
Cystinosis - Market Insights, Epidemiology & Forecast to 2028
Jan 06, 2020
Mylan to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 17, 2019
Auto-Injector Market Report Highlights Sales Volume, Price, Revenue, Gross Margin, Historical Growth & Future Perspectives by 2023: Radiant Insights, Inc.
Dec 05, 2019
Glucosamine Market Analysis & Potential Growth Opportunities 2023 | Key Players: Teva Pharmaceutical, Mylan, Nutralife Health Products, Blackmores, NOW Health Group, & Foodchem: Radiant Insights, Inc.
Nov 26, 2019
$216.94 Billion Generic Pharmaceutical Market Size, Share, Manufacturers & 2022 Forecasts In Exclusive Report By TBRC
Nov 25, 2019
Mylan to Present at the Evercore ISI HealthCONx Conference
Nov 21, 2019
STI Pharma Appoints Frank Mullery as President and Chief Commercial Officer
Nov 12, 2019
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
Nov 11, 2019
Generics Markets, 2030 - Focus on Value-Added Medicines & Supergenerics
Nov 11, 2019
Generic Oncology Drugs Market to 2027 - Global Analysis and Forecasts by Molecular Type, Indication, and Geography
Oct 29, 2019
Bryn Pharma Presents Data Demonstrating Patient Preference for Bi-dose Epinephrine Nasal Spray over EpiPen®
Oct 25, 2019
Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance
Oct 24, 2019
Mylan to Release Third Quarter 2019 Financial Results on Nov. 5, 2019